Rigel Pharmaceuticals RIGL Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's operating lease right-of-use assets in other assets?
- Rigel Pharmaceuticals (RIGL) reported operating lease right-of-use assets in other assets of $785K in Q1 2026.
- How has Rigel Pharmaceuticals's operating lease right-of-use assets in other assets changed year-over-year?
- Rigel Pharmaceuticals's operating lease right-of-use assets in other assets decreased by 39.8% year-over-year, from $1.31M to $785K.
- What is the long-term trend for Rigel Pharmaceuticals's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Rigel Pharmaceuticals's operating lease right-of-use assets in other assets has grown at a -44.8% compound annual growth rate (CAGR), from $17.9M to $920K.